| Core Binding Factor Acute Myeloid Leukemia studied in …STUDIED_INderived10 of 175show all (up to 200) |
|---|
| → studied in | NCT06917911Phase 2 · recruiting Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 175 trials mapped (7 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 175 trials mapped (7 active) | — | — | Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02094794Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML · condition mapped ALIAS · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085124Phase 3 · completed Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ALIAS · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · condition mapped ALIAS · 175 trials mapped (7 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |